Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence

INTRODUCTION: The purpose of this study was to explore the efficacy and safety of afatinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations based on real-world evidence. MATERIALS AND METHODS: Eligible real-world studies were identified f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lemeng, Luo, Yongzhong, Chen, Jianhua, Cheng, Tianli, Yang, Hua, Pan, Changqie, Li, Haitao, Jiang, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710163/
https://www.ncbi.nlm.nih.gov/pubmed/34961817
http://dx.doi.org/10.1155/2021/8736288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710163/
https://www.ncbi.nlm.nih.gov/pubmed/34961817
http://dx.doi.org/10.1155/2021/8736288

Ejemplares similares